Home » Topics » Disease categories and therapies » Endocrine/metabolic

Endocrine/metabolic
RSS

Spine-Tech and Sulzer Orthopedics Biologics announce alliance

Oct. 6, 1997

Mitsui Toatsu's hGH enters clinical testing this month

Oct. 6, 1997

Efficacy of cholesterol biosynthesis inhibitor demonstrated in dogs

Oct. 6, 1997

Safety and efficacy data for INVICORP reported at impotence meeting

Oct. 6, 1997

SS-Cream evaluated in subjects with premature ejaculation

Oct. 6, 1997

Regeneron and P&G joint development program for obesity

Oct. 3, 1997

L-Arginine not associated with objective improvement in organic ED

Oct. 3, 1997

Linsidomine + moxisylyte for ED

Oct. 3, 1997

Effects of BQ-123 and BQ-788 on ET-1-induced corpus cavernosum contractions

Oct. 3, 1997

Intracavernous moxisylyte recommended for first-line treatment of ED

Oct. 3, 1997

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 17, 2025.
Medline raises $6.3B in fourth med-tech IPO of December
BioWorld MedTech
Medline Inc. returned to the public markets with a blockbuster IPO of $6.26 billion, reportedly this year’s largest IPO globally. The upsized offering of more...
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 17, 2025.
Vitesse finesse pays off: DBV wins in peanut allergy phase III
BioWorld
DBV Technologies SA’s pivotal phase III trial with the Viaskin Peanut allergy patch came through for the company, and officials plan a BLA filing with the U.S....
Acryl raises $28M IPO, aiming to bridge medical divide with AI
BioWorld MedTech
Acryl Inc. debuted on South Korea’s Kosdaq Dec. 16, raising ₩42.12 billion ($28.5 million) in an IPO. Shares (KOSDAQ:0007C0) closed at ₩67,000 on the first day,...